Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Nov 19, 2014 · 10-Q · 50 days after period end · 0001424884-14-000121
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$1.57M | -$744.65K | -$976.96K | -$844.28K |
| EPS Diluted | -$0.09 | -$0.76 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 19, 2014 · 50 d after period end
